About: Carl J Pepine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Carl J Pepine Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) 研究者 (zh) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Carl J Pepine (en) Carl J Pepine (es) Carl J Pepine (nl) Carl J Pepine (ast) Carl J. Pepine (cs)
skos:prefLabel	Carl J Pepine (en) Carl J Pepine (es) Carl J Pepine (nl) Carl J Pepine (ast) Carl J. Pepine (cs)
name	Carl J Pepine (en) Carl J Pepine (es) Carl J Pepine (nl) Carl J Pepine (ast) Carl J. Pepine (cs)
Scopus author ID	wds:Q57013135-04DEA995-06C2-423F-8CB8-655D50969431
Scopus author ID	35353341300
given name	wds:Q57013135-65D34E26-45A3-4439-B38F-7982D124D326
given name	Carl
instance of	wds:Q57013135-AC887FF9-2366-4557-AC23-40BC6BB1503E
NL CR AUT ID	wds:Q57013135-54CB09EE-411F-4E22-B72F-3DB46D33D047
instance of	Homo sapiens
NL CR AUT ID	nlk20050164126
skos:altLabel	Carl Pepine (en)
occupation	wds:Q57013135-D97A5A06-44C0-478D-9147-3F31CE698162
employer	wds:Q57013135-0F721CED-9D82-4AA2-91DF-945AE6FD953C wds:Q57013135-5B5C467A-025D-42F4-AAD5-50349C079596 wds:Q57013135-992D4E01-D396-493A-B05D-52DFA616588C wds:Q57013135-C3B35150-BBEA-4AA3-902F-86289F8EC639 wds:Q57013135-D152D3A2-CFD3-4D7B-91A2-98943D772A21
NUKAT ID	wds:Q57013135-398805DF-659C-4694-B7F8-294C0052C772
sex or gender	wds:Q57013135-7F0BA0E1-8460-4D2E-9BFF-5421436562D9
ISNI	wds:Q57013135-A711355A-B4D7-4943-A9B2-3AD95A8C3930
VIAF ID	wds:Q57013135-6BB13EA1-D210-41F8-A55E-995EDAD150C9
IdRef ID	wds:Q57013135-39A049B4-25A5-4BFE-9946-6C00788B5FE6
date of birth	wds:Q57013135-629378E4-508D-4517-B742-906F2F7874EC
National Library of Israel J9U ID	wds:Q57013135-8363B7F9-D7DD-42C1-9307-439C24750E96
VIAF ID	http://viaf.org/viaf/49292526
IdRef ID	http://www.idref.fr/032002602/id
occupation	researcher
employer	J. Hillis Miller Health Science Center University of Florida Health Sciences Center Malcom Randall VA Medical Center
NUKAT ID	n2004041002
sex or gender	male
ISNI	0000000116380210
VIAF ID	49292526
IdRef ID	032002602
date of birth	1941-01-01 00:00:00Z (xsd:dateTime)
National Library of Israel J9U ID	987007342006005171
ORCID iD	wds:Q57013135-34DE3B69-598E-4AAA-BA42-C7D388A46820
ORCID iD	https://orcid.org/0000-0002-6011-681X
ORCID iD	0000-0002-6011-681X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57013135
is author of	The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation Loci influencing blood pressure identified using a cardiovascular gene-centric array Sertraline treatment of major depression in patients with acute MI or unstable angina Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network Obesity paradox in patients with hypertension and coronary artery disease. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome. 2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g Clinical implications of endothelial dysfunction. Gut dysbiosis is linked to hypertension. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the Nation Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascul Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia Verapamil use in patients with cardiovascular disease: an overview of randomized trials Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 134 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software